Correlation between heparin anti‐Xa activity and thromboelastography in adult critically ill COVID ‐19 patients
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · 2023
DOI: 10.1002/phar.2829 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023. Verfasst von Mitchell S Buckley und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Banner University Medical Center Phoenix, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Heparin, COVID-19. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
Study Objective Severe coronavirus disease 2019 (COVID‐19) increases the risk of thrombotic complications with unfractionated heparin (UFH) as a commonly used agent in managing venous thromboembolism (VTE). The optimal anticoagulation intensity and monitoring parameters in intensive care unit (ICU) COVID‐19 patients remains controversial. The primary study aim was to evaluate the relationship between anti‐Xa and thromboelastography (TEG) reaction (R) time in patients with severe COVID‐19 receiving therapeutic UFH infusions.
Design
Single‐center, retrospective study conducted over a 15‐month period (2020–2021).
Setting
Academic medical center (Banner University Medical Center Phoenix). Patients Adult patients with severe COVID‐19 administered therapeutic UFH infusions with one or more corresponding TEG, and anti‐Xa assessments drawn within ≤2 hours of each other were included. The primary end point was the correlation between anti‐Xa and TEG R time. Secondary aims were to describe the correlation between activated partial thromboplastin time (aPTT) and TEG R time, as well as clinical outcomes. Pearson's coefficient was used to evaluate the correlation using a kappa measure of agreement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Banner University Medical Center Phoenix, Phoenix, Arizona, USA.
- Department of Pharmacy, Loyola University Medical Center, Maywood, Illinois, USA.
- Department of Pharmacy, Wesley Medical Center, Wichita, Kansas, USA.
- Department of Pharmacy, New York-Presbyterian Hospital, New York, New York, USA.
- Department of Clinical Pharmacy, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado, Aurora, Colorado, USA.
ORCID-Profile: Mitchell S Buckley, Amy L Dzierba, Robert MacLaren
Zitieren
APA
Buckley, M. S., Benanti, G. E., Gilbert, B., Meckel, J., Dzierba, A. L., & MacLaren, R. (2023). Correlation between heparin anti‐Xa activity and thromboelastography in adult critically ill COVID ‐19 patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. https://doi.org/10.1002/phar.2829
Vancouver
Buckley MS, Benanti GE, Gilbert B, Meckel J, Dzierba AL, MacLaren R. Correlation between heparin anti‐Xa activity and thromboelastography in adult critically ill COVID ‐19 patients. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2023. doi:10.1002/phar.2829
BibTeX
@article{Buckley2023,
author = {Buckley, Mitchell S and Benanti, Grace E and Gilbert, Brian and Meckel, Jordan and Dzierba, Amy L and MacLaren, Robert},
title = {Correlation between heparin anti‐Xa activity and thromboelastography in adult critically ill COVID ‐19 patients},
journal = {Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy},
year = {2023},
doi = {10.1002/phar.2829}
}
EUVIMED